藥物交互作用
Dalfampridine + Linagliptin-metformin
嚴重程度: 中度
Dalfampridine and Linagliptin-metformin: moderate interaction.
最後更新
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
摘要
Both metformin and dalfampridine are eliminated partly by renal OCT2-mediated secretion, so they could compete and raise each other's concentrations. Higher dalfampridine exposure raises seizure risk, particularly in patients with reduced renal function.
用白話說明這項交互作用的意義
Dalfampridine and Linagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Dalfampridine belongs to Central Nervous System; Linagliptin-metformin belongs to Endocrine.
為什麼會發生
Competition at renal organic cation transporter 2 may reduce tubular secretion of both drugs.
處置方式
Check renal function before and during co-therapy and monitor for dalfampridine toxicity such as seizures or metformin adverse effects. Avoid in patients with moderate or severe renal impairment.
可向藥師詢問的問題
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Linagliptin-metformin 的其他交互作用
Dalfampridine 的其他交互作用
常見問題
Can I take Dalfampridine with Linagliptin-metformin?
MediHelp rates the interaction as moderate. Dalfampridine and Linagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both metformin and dalfampridine are eliminated partly by renal OCT2-mediated secretion, so they could compete and raise each other's concentrations. Higher dalfampridine exposure raises seizure risk, particularly in patients with reduced renal function.
How serious is the interaction between Dalfampridine and Linagliptin-metformin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check renal function before and during co-therapy and monitor for dalfampridine toxicity such as seizures or metformin adverse effects. Avoid in patients with moderate or severe renal impairment.
What other medicines interact with Linagliptin-metformin?
MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
